Studies have shown that inhibition of the FXR signal conduction in the intestine could reduce the synthesis of liver fatty acids and the ceramide in the intestine, thereby reducing the accumulation of liver lipids and improving HFD induced NAFLD (8). The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.